- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Arizona Revives Its Children's Health Insurance Program
What we're reading: Arizona revives its Children's Health Insurance Program; new medical schools focus on creating a new type of physician; and Cigna believes its deal with Anthem won't close until 2017.
A week after Arizona lawmakers chose not to restore the federal Children’s Health Insurance Program, making it the only state to not participate, the program was revived. The Arizona Legislature agreed to attach the program to another bill and the amended measure received enough votes to restore the program, reported Arizona Public Media. The program provides subsidized healthcare for 30,000 children, but enrollment was frozen 6 years ago.
New medical schools popping up around the country are focusing on creating a new type of physician who can fix the American healthcare system. These schools are focusing on rewarding preventive care and long-term value, involving physicians are community organizations, and spurring behavioral change in patients, according to STAT. Well-established schools, like Harvard Medical School, are also revamping their curriculum to promote the new style of caring for patients.
Cigna believes that the deal to be bought by Anthem may not close until 2017. According to The New York Times, the complexity of the regulatory process may push back when the deal is closed; however, Anthem still expects the deal to close in 2016. The Department of Justice is simultaneously reviewing Aetna’s purchase of Humana.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
April 17th 2025Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy initiation and highlighting the need for more inclusive guidelines.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
